A randomized controlled trial of CT angiography prior to percutaneous tumor ablation for hepatocellular carcinoma

A randomized controlled trial of CT angiography prior to percutaneous tumor ablation for hepatocellular carcinoma - A randomized controlled trial of CT angiography prior to tumor ablation for HCC

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-C000000070

Enrollment

280

Registered

2005-09-01

Start date

2004-09-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hepatocellular carcinoma

Interventions

CT angiography prior to percutaneous tumor ablation for hepatocelluar carcinoma Percutaneous tumor ablation to hepatocellular carcinoma without CT angiography

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients diagnosed as typical (hypervascular) hepatocellular carcinoma by dynamic CT Patients who have no more than 3 hepatocellular carcinoma nodules, each 3cm or less in diameter Well preserved liver function (Child A)

Exclusion criteria

Exclusion criteria: Patients who have allergy to contrast media Patients who have extrahepatic metastasis Patients with severely impaired renal function Patients with severe coagulopathy

Design outcomes

Primary

Measure	Time frame
Recurrence free survival after percutaneous tumor ablation for hepatocellular carcinoma	—

Secondary

Measure	Time frame
Newly detected cancer nodules by CT angiography	—

Countries

Japan

Contacts

Public ContactRyosuke Tateishi

University of Tokyo, Graduate School of Medicine Department of Gastroenterology

tateishi-tky@umin.ac.jp03-3815-5411

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026